# Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer

> **NCT00976456** · PHASE3 · COMPLETED · sponsor: **PD Dr. med. Wolfgang Schuette** · enrollment: 271 (actual)

## Conditions studied

- Non-squamous Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Bevacizumab + Pemetrexed
- **DRUG:** Bevacizumab + Pemetrexed + Carboplatin

## Key facts

- **NCT ID:** NCT00976456
- **Lead sponsor:** PD Dr. med. Wolfgang Schuette
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2016-03-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976456, "Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00976456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*